Delivery Order SPE2DB20D1051-SPE2DB24FD8HM

Award Date 6/14/24
Potential Completion Date 7/9/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order contract is for the supply of ORGOVYX 120 MG TABLET and has an ultimate completion date of December 17, 2024. Amerisourcebergen, as the prime contractor, has been awarded an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the drug ORGOVYX 120 MG TABLET, with a completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,329.89, was issued by the Medical Supply Chain division of the U.S. Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564677408 ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of June 12, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 Firm Fixed Price Delivery Order contract is for the supply of ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed-price delivery order contract valued at $1,329.89 by the Defense Logistics Agency (DLA) to provide ORGOVYX 120 MG TABLET UU 30S, a specialty pharmaceutical product. The contract has a completion date of March 1, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle for delivering...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,329.89 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medical products. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The award is a Delivery Order contract valued at $1,329.89 for the supply of the medication ORGOVYX 120 MG Tablet. The contract has an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $6,649.45 firm fixed-price delivery order is for the provision of 4565069495 - ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, with a completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the delivery of the prescription drug ORGOVYX 120 MG TABLET. The $1,329.89 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD). The contract has a completion date of June 21, 2024. Amerisourcebergen also holds a larger $999,999,999.00 Indefinite...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD8HM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a large pharmaceutical distribution company. The $1,329.89 Firm Fixed Price Delivery Order Contract is for the supply of ORGOVYX 120 MG TABLET medication. The contract has no set-aside designation and has an ultimate completion date of July 9, 2024.

Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 9/13/24, 10:17 AM